Infliximab - CISMeF

Preferred Label : Infliximab;

MeSH definition : A chimeric monoclonal antibody to TNF ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.; A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.;

MeSH synonym : MAb cA2; Monoclonal Antibody cA2; cA2, Monoclonal Antibody; Antibody cA2, Monoclonal;

MeSH hyponym : remicade; Infliximab dyyb; Infliximab abda;

MeSH Related Number : 170277-31-3;

Wikipedia link : https://en.wikipedia.org/wiki/Infliximab;

Is substance : O;

UNII : B72HH48FLU;

Details

Origin ID

D000069285;

UMLS CUI

C0666743;

ATC code(s)
- infliximab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- infliximab [EMDN type]
CISMeF manual mappings
- Infliximab [Substance BNPC]
- Infliximab [NCIt concept]
- Infliximab (substance) [SNOMED CT concept]
- inFLIXimab [LOINC component]
False automatic mappings
- Ifosfamide [NCIt concept]
Pharmacological action(s)
- Tumor Necrosis Factor Inhibitors [MeSH Descriptor]
- antirheumatic agents [MeSH Descriptor]
- dermatologic agents [MeSH Descriptor]
- gastrointestinal agents [MeSH Descriptor]
Record concept(s)
- Inflectra [MeSH concept]
- Infliximab-abda [MeSH concept]
- Infliximab-dyyb [MeSH concept]
- Renflexis [MeSH concept]
- infliximab [MeSH concept]
- remicade [MeSH concept]
Related MeSH Supplementary Concept(s)
- BCD-055 [MeSH Supplementary Concept]
- GP1111 [MeSH Supplementary Concept]
- SB2 infliximab [MeSH Supplementary Concept]
See also
- tumor necrosis factor-alpha [MeSH Descriptor]
See also inter- (CISMeF)
- Infliximab Given for Kawasaki Disease [NCIt concept]
- Product containing infliximab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Infliximab [Substance BNPC]
- Infliximab [NCIt concept]
- Infliximab (substance) [SNOMED CT concept]
- Product containing infliximab (medicinal product) [SNOMED CT concept]
- inFLIXimab [LOINC component]
- infliximab [ATC Code]
Validated automatic mappings to BTNT
- infliximab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients